ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bullish•Samsung Biologics
•11 Nov 2016 06:05

Recap of Samsung BioLogics' First Trading Day - Foreign Institutions Net Purchased 1M Shares

Samsung BioLogics closed at ₩144,000 with 6.67% gain on its first trading day. It started with a relatively weak sentiment at the opening price of...

Logo
329 Views
Share
bullish•Samsung Biologics
•10 Nov 2016 06:20

Samsung BioLogics' First Trading Day - Blunders in Barron's Argument & Price Prediction

As reported by Barron's on Nov 5 ("Samsung BioLogics IPO: Too Expensive"), there are still some skeptical views on BioLogics' IPO valuation....

Logo
407 Views
Share
bearish•Celltrion Inc
•04 Nov 2016 02:56

One World, Two Stories

Celltrion's management continues to make very optimistic projections about Remsima's US sales in 2017 despite regulatory hurdles that will limit...

Share
bullish•SillaJen Inc
•03 Nov 2016 11:26

SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...

Logo
349 Views
Share
•01 Nov 2016 23:07

Korea National Pension Fund - Commitment to Buy 1 Trillion Won Worth of Small Cap Stocks in Korea

On October 26th, The Korea National Pension Fund (KNPF) announced that it will purchase 1 trillion won worth of small-mid cap stocks on the Korean...

Logo
238 Views
Share
x